Dr. Michael E. Sekela, MD

Dr. Sekela practices at Centerpoint Health - Winchester in Winchester, Kentucky, part of Lifepoint Health.

Dr. Sekela's NPI, 1649254137, was assigned on November 30, 2005. Dr. Sekela graduated from Albert Einstein College of Medicine of Yeshiva University in 1981. Dr. Sekela holds Kentucky license 24562.

Dr. Sekela's primary practice is Centerpoint Health - Winchester, at 175 Hospital Drive, Winchester, KY 40391 in Clark County. The practice phone is (859) 737-8559.

Dr. Sekela's primary practice is Centerpoint Health - Winchester in Winchester, Kentucky, part of Lifepoint Health. Dr. Sekela is also affiliated with University of Kentucky Albert B. Chandler Hospital. The medical group on file is University of Kentucky General Pediatrics. Dmand AI also links Dr. Sekela to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sekela practices, 3 sites in all. Vendor and product names are available with a free account.

Thoracic surgery (cardiothoracic vascular surgery) is Dr. Sekela's primary specialty in the NPI Registry, under taxonomy code 208G00000X. Dr. Sekela is licensed in Kentucky.

CMS data shows 147 Medicare services from Dr. Sekela across 6 procedure codes in 2024, for 92 Medicare patients. Medicare paid $37,980 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 92 Medicare patients who saw Dr. Sekela in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sekela's median patient age at 68, with 37% women.

In 2024, Dr. Sekela wrote 117 Medicare Part D claims for 37 patients. 94% of them were for generic drugs. CMS names the drug for 54 of them, across 4 drugs with 11 or more claims each, at $1,354 in total drug cost. In 2023, CMS named 46 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Sekela for performance year 2024, reported as part of a group. Dr. Sekela accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of coronary artery bypass graft (cabg) by Dr. Sekela, more than 50% of the clinicians it reports for that procedure.

Dmand AI links 25 papers to Dr. Sekela, published from 2016 to 2025. 2024 was the busiest year, with 8. The most frequent topics are Endocarditis, COVID-19 and Graft Survival. Dr. Sekela has published most often in Open Forum Infect Dis. Dr. Sekela's most frequent co-authors are Talal Salem Alnabelsi, MD, John C. Gurley, MD and Erinn Amanda Ogburn, MD.

Dmand AI links Dr. Sekela to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Heart Valve Diseases and Heart Diseases. On-X Life Technologies, Inc. sponsors the most, 2.

CMS Open Payments shows 31 general payments to Dr. Sekela from 10 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 68% of the total. Cerus Corporation paid the most, $3,627.

Dr. Sekela graduated from Albert Einstein College of Medicine of Yeshiva University in 1981.